The incidence of AML1/ETO is 5-10% higher when molecular biology approaches are used.20,39,40,41 The prognosis for AML/ETO-positive cases in the absence of t(8:21) has been reported to be poor, as was found in our case.41 This evidence concerns the gene RUNX1T1 and acute myeloid leukemia.